Bavarian Nordic eyes European monkeypox approval for smallpox vaccine

Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.

Photo: Lukas Barth/Reuters/Ritzau Scanpix

Danish biotech firm Bavarian Nordic is the only firm in the world that has an approved vaccine for monkeypox – it just so happens not to be in Europe.

Bavarian’s vaccine has been approved for both smallpox and monkeypox in the US and Canada, where the product goes by the names Jynneos and Imvamune, respectively.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs